Free Trial

E. Ohman J or Asset Management AB Has $15.76 Million Position in Procter & Gamble Company (The) $PG

Procter & Gamble logo with Consumer Staples background

Key Points

  • E. Ohman J or Asset Management AB has reduced its stake in Procter & Gamble by 4.7%, now holding 98,935 shares valued at approximately $15.76 million.
  • CEO Gary A. Coombe and CEO Jon R. Moeller sold significant portions of their stock, with Coombe selling 10,194 shares and Moeller selling 40,119 shares, resulting in reductions of 22.57% and 11.16% in their ownership, respectively.
  • Wall Street analysts maintain an average price target of $175.12 for Procter & Gamble shares, reflecting a consensus rating of "Moderate Buy."
  • MarketBeat previews the top five stocks to own by October 1st.

E. Ohman J or Asset Management AB reduced its position in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 4.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 98,935 shares of the company's stock after selling 4,871 shares during the period. E. Ohman J or Asset Management AB's holdings in Procter & Gamble were worth $15,762,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of PG. Northern Trust Corp boosted its position in Procter & Gamble by 0.8% during the first quarter. Northern Trust Corp now owns 29,644,000 shares of the company's stock valued at $5,051,930,000 after purchasing an additional 248,792 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its position in Procter & Gamble by 13.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock valued at $3,660,737,000 after purchasing an additional 2,466,308 shares during the last quarter. Goldman Sachs Group Inc. boosted its position in Procter & Gamble by 3.5% during the first quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company's stock valued at $2,966,252,000 after purchasing an additional 583,629 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in Procter & Gamble by 6.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company's stock valued at $2,947,146,000 after purchasing an additional 1,018,865 shares during the last quarter. Finally, Royal Bank of Canada boosted its position in Procter & Gamble by 0.6% during the first quarter. Royal Bank of Canada now owns 17,273,679 shares of the company's stock valued at $2,943,779,000 after purchasing an additional 111,162 shares during the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on PG. UBS Group set a $180.00 price target on Procter & Gamble and gave the company a "buy" rating in a research report on Wednesday, July 30th. Wells Fargo & Company reduced their price target on Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating for the company in a research report on Wednesday, July 30th. Evercore ISI restated an "in-line" rating and issued a $170.00 price objective (down previously from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Barclays set a $164.00 price objective on Procter & Gamble and gave the company an "equal weight" rating in a research note on Thursday, July 31st. Finally, JPMorgan Chase & Co. restated a "neutral" rating and issued a $170.00 price objective (down previously from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. One equities research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $175.12.

Check Out Our Latest Analysis on PG

Insiders Place Their Bets

In other Procter & Gamble news, CEO Gary A. Coombe sold 10,194 shares of the firm's stock in a transaction dated Thursday, August 21st. The stock was sold at an average price of $158.16, for a total transaction of $1,612,283.04. Following the sale, the chief executive officer owned 34,978 shares in the company, valued at $5,532,120.48. This trade represents a 22.57% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Jon R. Moeller sold 40,119 shares of the firm's stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $6,309,515.13. Following the transaction, the chief executive officer directly owned 319,375 shares in the company, valued at $50,228,106.25. This trade represents a 11.16% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 120,181 shares of company stock valued at $18,918,012 in the last quarter. 0.20% of the stock is currently owned by company insiders.

Procter & Gamble Price Performance

Shares of NYSE PG opened at $158.02 on Monday. The firm has a market cap of $369.85 billion, a P/E ratio of 24.27, a price-to-earnings-growth ratio of 4.17 and a beta of 0.36. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. Procter & Gamble Company has a 1-year low of $149.91 and a 1-year high of $180.43. The business's 50 day moving average is $156.21 and its 200-day moving average is $161.77.

Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The firm had revenue of $20.89 billion during the quarter, compared to analyst estimates of $20.79 billion. During the same period last year, the company posted $1.40 EPS. The business's quarterly revenue was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities research analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were issued a $1.0568 dividend. The ex-dividend date of this dividend was Friday, July 18th. This represents a $4.23 annualized dividend and a dividend yield of 2.7%. Procter & Gamble's dividend payout ratio is currently 64.82%.

Procter & Gamble Profile

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Recommended Stories

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets Brace for Fed: What Investors Need to Know Before Wednesday
3 Biotech Stocks Under $5 With Huge Upside
Revealed: Congress’ Biggest Stock Moves This Month

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines